gene patents

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

The firm's CEO Kevin Ness said confirmation of MAD7's editing activity in human HEK293T cells shows the potential for Inscripta's technology.

A new analysis finds that one company filed most of the patents on genes from deep-sea organisms, the Independent reports.

A lawyer and a scientist say the best result in the CRISPR patent fight would be narrow patents that prevent anyone from controlling downstream innovation.

In February, the USPTO's Patent Trial and Appeal Board stopped UC's bid for IP underpinning the most lucrative applications of genome editing.

The plaintiffs say the USPTO made several errors when it determined the Broad Institute had the right to patent the use of CRISPR/Cas9 in eukaryotes.

Two Australian organizations are appealing a patent covering much of the cattle genome, according to ABC.

Arti Rai and Colleen Chien are studying whether the Supreme Court's decisions in Mayo v Prometheus and Bilski v Kappos have had a negative impact on diagnostics innovation.

Beef producers in Australia are fighting a bovine genome patent awarded to US companies, the ABC reports.

Fight, Fight, Fight!

The USPTO has become involved in the CRISPR-Cas9 patent dispute.

Pages

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.